*Studies up to 12 weeks; further treatment should be evaluated by the veterinarian.1. Lascelles BDX, Henry 3rd JB, Brown J et al (2010) Cross-sectional study of the prevalence of radiographic degenerative joint disease in domesticated cats. Vet Surg 39(5):535–544. 2. Lascelles BDX, Robertson SA (2010) DJD-associated pain in cats: what can we do to promote patient comfort? J Feline Med Surg 12(3):200–212. 3. Stamper C (2018) Osteoarthritis in cats: a more common disease than you might expect. Available at: https://www.fda.gov/animal-veterinary/animal-health-literacy/osteoarthritis-cats-more-common-disease-you-might-expect [Accessed January 2021]. 4. King JN, Hotz R, Reagan EL, et al (2012) Safety of oral robenacoxib in the cat. J Vet Pharmacol Ther 35(3):290–300. 5. Pelligand, L., King, J. N., Toutain, P. L., Elliott, J., Lees, P. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation. J. vet. Pharmacol. Therap. 35, 19–32. 6. Metacam® Summary of Product Characteristics. Onsior tablets for cats (6 mg) are indicated for the reduction of moderate pain and inflammation associated with orthopaedic surgery and for the treatment of pain and inflammation associated with acute or chronic musculoskeletal disorders in cats. Onsior solution for injection for cats and dogs (20 mg) is indicated for the treatment of pain and inflammation associated with orthopaedic or soft tissue surgery in cats. COX-2 = cyclooxygenase-2.
Onsior POM-V (UK) and POM (Ireland) contains robenacoxib.
Further information is available from the SPC. Advice should be sought from the Medicine Prescriber. Refer to the product packaging and leaflets for information about side effects, precautions, warnings and contra-indications. Contact Elanco Animal Health for further information on 01256 353131 or email email@example.com, or write to: Elanco Animal Health, Form 2, Bartley Way, Bartley Wood Business Park, Hook, RG27 9XA.
Onsior, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. Metacam is the trademark of Boehringer Ingelheim.
© 2021 Elanco or its affiliates. PM-IE-21-0040. Date of preparation: 03/21.Use medicines responsibly www.noah.co.uk/responsible, www.apha.ie.